Effect of Coenzyme Q10 on Diabetic Children

Launched by ASSIUT UNIVERSITY · Apr 10, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at the effects of a supplement called Coenzyme Q10 on children with Type 1 Diabetes. The goal is to see how this supplement might help manage blood sugar levels and a specific marker called glycosylated hemoglobin, which gives an idea of how well blood sugar has been controlled over time.

To participate, children must be between 2 and 18 years old, have been diagnosed with Type 1 Diabetes for at least one year, and be in generally good health. However, those who have had diabetes for less than a year, have other specific health conditions like thyroid or celiac diseases, or are diagnosed with types of diabetes other than Type 1 will not be eligible. As the trial is not yet recruiting, families interested in this study will need to wait until it begins, but it could be an opportunity to help researchers learn more about managing diabetes in children.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients diagnosed as type 1 diabetes mellitus from age of 2 years old to 18 years old with diabetes mellitus of duration at least 1 year.
• Exclusion Criteria:
• • - patients diagnosed as diabetes mellitus less than 2 years old .
• • patients with diabetes mellitus of duration less than 1 year.
• • patients diagnosed as type 1 diabetes mellitus with Thyroid or celiac diseases.
• • other types of hyperglycemia rather than Type 1 diabetes mellitus.